|
Raphael McmahonObserver |

As A.I. takes over analysis and research, consulting firms are being pushed to abandon billable hours and reinvent their value proposition.

The Boston biotech founded by Harvard professor David Sinclair is testing whether cellular reprogramming can turn back the clock on aging.
